Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2016 1
2018 2
2019 2
2020 5
2021 7
2022 10
2023 12
2024 9

Text availability

Article attribute

Article type

Publication date

Search Results

41 results

Results by year

Filters applied: . Clear all
Page 1
Clinical Pharmacokinetics and Pharmacodynamics of Dalbavancin.
Molina KC, Miller MA, Mueller SW, Van Matre ET, Krsak M, Kiser TH. Molina KC, et al. Clin Pharmacokinet. 2022 Mar;61(3):363-374. doi: 10.1007/s40262-021-01088-w. Epub 2021 Dec 21. Clin Pharmacokinet. 2022. PMID: 34931283 Review.
Real-world use of nirmatrelvir-ritonavir in outpatients with COVID-19 during the era of omicron variants including BA.4 and BA.5 in Colorado, USA: a retrospective cohort study.
Aggarwal NR, Molina KC, Beaty LE, Bennett TD, Carlson NE, Mayer DA, Peers JL, Russell S, Wynia MK, Ginde AA. Aggarwal NR, et al. Among authors: molina kc. Lancet Infect Dis. 2023 Jun;23(6):696-705. doi: 10.1016/S1473-3099(23)00011-7. Epub 2023 Feb 10. Lancet Infect Dis. 2023. PMID: 36780912 Free PMC article.
Real-world use of nirmatrelvir-ritonavir: who benefits?
Molina KC, Ginde AA. Molina KC, et al. Lancet Infect Dis. 2023 Jul;23(7):765-767. doi: 10.1016/S1473-3099(23)00180-9. Epub 2023 Mar 15. Lancet Infect Dis. 2023. PMID: 36933566 Free PMC article. No abstract available.
Nephrotoxicity of Vancomycin in Combination With Beta-Lactam Agents: Ceftolozane-Tazobactam vs Piperacillin-Tazobactam.
Alosaimy S, Lagnf AM, Hobbs ALV, Mubarez M, Kufel WD, Morrisette T, Polisetty RS, Li D, Veve MP, Simon SP, Truong J, Finch N, Venugopalan V, Rico M, Amaya L, Yost C, Cubillos A, Chandler E, Patch M, Smith IMK, Biagi M, Wrin J, Moore WJ, Molina KC, Rebold N, Holger D, Kunz Coyne AJ, Jorgensen SCJ, Witucki P, Tran NN, Davis SL, Sakoulas G, Rybak MJ. Alosaimy S, et al. Among authors: molina kc. Clin Infect Dis. 2023 Feb 8;76(3):e1444-e1455. doi: 10.1093/cid/ciac670. Clin Infect Dis. 2023. PMID: 35982631
Response to Pan et al.
Jenrette JE, Coronato K, Miller MA, Molina KC, Quinones A, Jacknin G. Jenrette JE, et al. Among authors: molina kc. Acad Emerg Med. 2024 Apr 21. doi: 10.1111/acem.14925. Online ahead of print. Acad Emerg Med. 2024. PMID: 38644581 No abstract available.
Response to Mahatanan and Kang: It's Complicated.
Molina KC, Mueller SW, Miller MA, Krsak M. Molina KC, et al. Open Forum Infect Dis. 2023 Apr 19;10(5):ofad210. doi: 10.1093/ofid/ofad210. eCollection 2023 May. Open Forum Infect Dis. 2023. PMID: 37180593 Free PMC article. No abstract available.
Early Experience With Eravacycline for Complicated Infections.
Alosaimy S, Molina KC, Claeys KC, Andrade J, Truong J, King MA, Pullinger BM, Huang G, Morrisette T, Lagnf AM, Davis SL, Rybak MJ. Alosaimy S, et al. Among authors: molina kc. Open Forum Infect Dis. 2020 Mar 2;7(5):ofaa071. doi: 10.1093/ofid/ofaa071. eCollection 2020 May. Open Forum Infect Dis. 2020. PMID: 32411809 Free PMC article.
41 results